Tag Archives: Regenerative Medicine Market

Transformative Effect of Regenerative Medicine on Human Health Benefits Global Market

Global Regenerative Medicine Market: Snapshot

Increasing application areas such as neurology, cardiovascular, musculoskeletal and orthopedic diseases will build up greater opportunities, states TMR. The market for regenerative medicine market appears to be fragmented in terms of competition. The Asia Pacific region will present large opportunities, displaying a promising CAGR between 2013 and 2019. The Asian countries such as South Korea, China, and Japan hold considerable prospects for augmentation of global regenerative medicine market. Smith & Nephew, a British medical equipment manufacturing company acquired Sushrut Surgical Pvt. Ltd., an India-based medical technology firm, enhancing access to the consumer pool in Asian countries in order to secure larger profits.

The global regenerative medicine market was pegged at US$2.5 mn in 2012. It is projected to achieve US$6.4 mn by the end of 2019, expanding at a progressive CAGR of 12.8% during the forecast period.

Read Full Report: http://www.transparencymarketresearch.com/regenerative-medicines-market.html

North America Leads Due to Increasing Bone and Joint Reconstructive Surgeries

North America, owing to a large number of leading companies operating in regenerative medicine, dominates the global regenerative medicine market. The ongoing expansive research and development activities in the U.S. will also drive the North America segment. The bone and joint regenerative medicine market is the leading application segment in this region, as a high demand for regenerative medicine is exhibited.

The region of Asia Pacific will witness monumental growth because of its massive consumer pool, rising disposable incomes of people, and growing healthcare expenditure. Over the coming years, the regenerative medicine market in Asia Pacific will benefit from the growing demand for orthopedic surgeries, technological innovations, high incidence of joint and bone diseases, and increasing awareness about regenerative medicine. However, the market might face challenges such as high costs and regulatory policies.

Japan displays great potential on account several favorable factors. Fewer regulatory restraints, coupled with technological advancements in the area of regenerative medicine will ensure market expansion in the country. One key technological development is the emergence of 3D tissue bioprinters that enable the creation of blood vessels, cartilage, skin and other tissues.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419

Extensive Research in Stem Cell Therapy to Promote Growth

Bio-based alternatives such as stem cell therapy and tissue engineering have gained prominence despite the rapid development of synthetic options. The high generative power of stem cells enables the production of other cells in the body. This feature of stem cells has raised demand for stem cell therapies. Additionally, stem cell therapy is used in the treatment of diseases such as cancer, retinal diseases, Alzheimer’s, diabetes, heart failure treatment, rheumatoid arthritis, autism spectrum, multiple sclerosis, cerebral palsy, and osteoarthritis, among others. It is projected that stem cells will occupy an important portion of regenerative medicine market over the coming period. Therefore, large-scale research activities have been undertaken in order to tap their full potential. However, factors such as ethical issues related to the use of embryonic stem cells might pose a threat to further expansion.

Notwithstanding the advancement of the stem cell therapy segment, the biomaterials segment is expected to retain its foremost position in the global regenerative medicine market. The largest amount of shares were held by this segment in 2012 on account of great demand for biomaterials and supportive reimbursement policies.

The key players operating in the global regenerative medicine market are Stryker Corporation (Vitoss Bone Graft Substitute), DePuy Synthes, Inc. (Healos Bone Graft), CONMED Corporation, Arthrex, Inc., Zimmer Holdings, Inc. (CopiOs Bone Void Filler), and Medtronic, Inc.(INFUSE Bone Graft).

 

Transformative Effect of Regenerative Medicine on Human Health Benefits Global Market

Focus on stem cell therapy and tissue engineering to regenerate and reconstruct bone tissue is a next big thing in the life science industry. Manufacturers involved in the field are focused on development of improved tissue engineering and stem cell therapy based bone and joint application products in the market. Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. The U.S. National Institute of Health states, regenerative medicine is the process of creating active and efficient tissues that has lost its function due to the following age, congenital defect, damage and due to various disease. Regenerative medicine has wide application areas such as neurology, orthopedic, cardiovascular and musculoskeletal diseases. Industry experts believe that regenerative medicine is expected to revolutionize the bone and joint application market making the products an integral part of bone and joint reconstructive surgeries.

Read Full Report: http://www.transparencymarketresearch.com/regenerative-medicines-market.html

For the first time, skin grafts were made by Heinrich Christian Bunger in 1842 and it was successful analogous during skin transplantation. Moreover, modern kidney transplant was performed successfully for first time in the year 1954, where regenerative medicine procedure was used extensively for that transplantation. Over the past few decades regenerative medicine applications have witnessed a paradigm shift from organ to tissue regeneration and repair. In recent times, technologies that are utilized for making regenerative medicine bone and joint products are improved significantly due to rising prevalence of various arthritis disorder coupled with increasing geriatric population worldwide. However, ethical issues pertaining to stem cell therapy would restrict the regenerative medicine bone and joint product to some extent in the global market.

Regenerative medicine is a biological heterogeneous domain that acts therapeutically by augmenting and stimulating the body’s capacity for regeneration and self repair. Transparency Market Research, a leading U.S.-based Market Research firm, analyses the market for regenerative medicine bone and joint application and predicts it to grow at a compounded annual growth rate of 12.8% for the period 2013 to 2019.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419

It was also observed that manufacturer of regenerative medicine bone and joint products are expanding their operation in Asian countries (China, Japan, India and South Korea) as these countries grasp enormous potential for regenerative medicine bone and joint application.

Thus, it can be securely concluded that the future of the regenerative medicine (bone and joint) industry holds immense potential for market growth due to the introduction of innovative technology (tissue engineering) for product development. Moreover, private companies and government organizations have invested a huge amount in research and development activities to bring revolutionary persistent product in the market, which will further augment the uptake of these product.

Vendors who are operating in the global regenerative medicine bone and joint application market includes DePuy Synthes, Inc., Medtronic, Inc., Stryker Corporation, Zimmer Holdings, Inc., Stryker Corporation and Smith and Nephew PLC.

Transformative Effect of Regenerative Medicine on Human Health Benefits Global Market

Regenerative medicines are an emerging field of medical science aimed at regeneration, repair, or replacement of damaged tissue and organs. As per the U.S. National Institute of Health, regenerative medicine is the procedure of creating functional tissues to repair and/or replace nonfunctional organs or tissues. With regenerative medicines, tissues or organs that have lost their functioning power due to congenital defects, age, and external or internal damage are repaired or replaced. Some of the application areas of regenerative medicines are neurology, cardiovascular, orthopedic, and musculoskeletal disorders.

Factors such as technological advancements in stem cell therapy and tissue engineering are predicted to propel the global regenerative medicine market during the forecast period. However, ethical issues, post-implantation infections and complications, and regulatory constraints are expected to hamper the growth of the global regenerative medicine market in the years to come. Leading players are focusing on capturing the untapped market to increase their share in the global market. The high number of mergers, acquisitions, and partnerships expected to occur in the coming years is predicted to make the global regenerative medicine market highly competitive in the near future.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419

The global regenerative medicine market is segmented on the basis of technology, application, and geography. Based on geography, the global regenerative medicine market is divided into Asia Pacific, Europe, North America, and Rest of the World. In 2012, the global regenerative medicine market was dominated by North America due to the rising demand for bone and joint reconstructive surgeries. The region’s increasing aging population is predicted to propel the Europe regenerative medicine market in the next few years. Going forward, Asia Pacific is expected to register considerable growth in the global regenerative medicine market.

Companies such as DePuy Synthes, Inc. (HEALOS Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute), Zimmer Holdings, Inc. (CopiOs Bone Void Filler), and Medtronic, Inc. (INFUSE Bone Graft) are expected to lead the global regenerative medicine market in the years to come. The entry of new players is predicted to create new growth opportunities in the near future.

By technology, the global regenerative medicine market is classified into stem cell therapy, tissue engineering, and biomaterials. In 2012, the biomaterials segment dominated the global regenerative medicine market due to factors such as favorable reimbursement policies. Moreover, strong demand for biomaterials is predicted to propel the segment in the coming few years.

Read Full Report: http://www.transparencymarketresearch.com/regenerative-medicines-market.html

 

Global Regenerative Medicine Market Set to Register 12.8% CAGR due to Rising Tissue Engineering and Stem Cell Therapy

Regenerative medicine, according to the US National Institutes of Health (NIH), is the process of developing functional tissues for the repair and/or replacement of damaged organs or tissues. Having lost function due to disease, congenital defects, and age, these tissues or organs are regenerated to establish and restore normal function.

Regenerative medicine is used in a wide range of applications including neurology, musculoskeletal, cardiovascular, and orthopedic. Earlier this month, a study showed that a new regenerative medicine appears to relieve eye pain, light sensitivity, and burning, and stimulate faster tissue repair following eye surgery. Findings by a team of researchers in Turkey suggest that this new compound can be beneficial for all those patients who undergo refractive surgery and corneal implants.

Read Full Report: http://www.transparencymarketresearch.com/regenerative-medicines-market.html

Demand for Tissue Engineering to Rise amid High Cost of Biomaterials

Regenerative medicine is an emerging branch of medical science and is being extensively used to treat cardiovascular disease, musculoskeletal disease, and orthopedic disorders. The growing prevalence of bone and joint disorders and the rise in orthopedic surgeries have fuelled the demand for regenerative medicines. Furthermore, technological innovations in stem cell therapy, biomaterials, and tissue engineering have supported the growth of the global regenerative medicines market. However, regulatory constraints pose a threat to the development of regenerative medicines. “Ethical issues related to allogeneic bone grafts and stem cell therapy, and post implantation infections are impeding the growth of the overall market,” the analyst states.

Technology has played a pivotal part in the success of regenerative medicines. Favorable reimbursement policies had augmented the demand for biomaterials in 2012. However, tissue engineering is being increasingly preferred over biomaterials. In fact, during the period between 2013 and 2019, tissue engineering is anticipated to expand at the fastest pace. “The high cost of biomaterials has led to their decreased adoption among patients,” the analyst mentions.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419

The global regenerative medicine market is anticipated to expand at a CAGR of 12.8% during the period between 2013 and 2019. The overall market stood at a valuation of US$2.6 bn in 2012 and is projected to be worth US$6.5 bn by 2019.

Global Regenerative Medicine Market: Geographical Segmentation

Regionally, North America is the key contributor to the global regenerative medicine market due to the presence of several leading market players in the region, which has led to the latest advances in the field becoming easily available to patients. The well-funded R&D environment in the U.S. is also a key driver for the North America bone and joint regenerative medicine market, which is likely to remain a dominant regional market for regenerative medicine in the coming years.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=419

Asia Pacific is likely to emerge as a leading regional market for bone and joint regenerative medicine in the coming years. The increasing patient pool of bone and joint conditions and the steady rise in healthcare expenditure in Asia Pacific are vital in ensuring sustained growth of the Asia Pacific regenerative medicine market in the coming years. Many key multinational players in the regenerative medicine market have identified Asia Pacific as a high-potential market for the future and have accordingly taken steps to expand their presence in the region.

Key players examined in the report include Smith & Nephew plc, Anika Therapeutics Inc., DePuy Synthes Inc., Baxter International Inc., Stryker Corporation, Medtronic Inc., Arthrex Inc., Zimmer Holdings Inc., and CONMED Corporation.

 

Global Regenerative Medicine Market Set to Register 12.8% CAGR due to Rising Tissue Engineering and Stem Cell Therapy

Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. Technological advancement in tissue engineering and stem cell therapy is expected to drive the global market for regenerative medicine (bone and joint). Moreover, growing prevalence of bone and joint disorder has also accounted for the market growth of the global regenerative medicine (bone and joint). However, factors such as stringent regulatory compliance, ethical issues pertaining to stem cell therapy and post implantation rejection are expected to hinder the global market growth during the forecast period. The global regenerative medicine (bone and joint) market was valued at USD 2,589.5 million in 2012 and is expected to grow at a CAGR of 12.8% from 2013 to 2019, to reach an estimated value of USD 6,473.4 million by 2019.

The global market for regenerative medicine is segmented based on technology as stem cell therapy, biomaterials and tissue engineering. In 2012, biomaterials segment accounted for the largest market share in the global regenerative medicine (bone and joint) market owing to favorable reimbursement policies and strong demand of biomaterials in the global market. Moreover, tissue engineering is expected to grow at the highest CAGR during the forecast period.

In addition, the global market for regenerative medicine (bone and joint) is segmented based on application as bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. In 2012, bone graft substitute segment accounted for the largest market share in the global regenerative medicine bone and joint application market owing to growing demand of bone graft substitute in orthopaedic surgeries. Autogenic bone application segment is expected to grow at the highest CAGR during the forecast period 2013 to 2019.

North America was the largest market for regenerative medicine bone and joint application in 2012, accounting for largest market share of the total regenerative medicine (bone and joint) market. The regenerative medicine market in North America witnessed significant growth due to increasing demand of bone and joint reconstructive surgeries. Moreover, favorable government initiatives have also supported the growth of the regenerative medicine bone and joint application market in this region. European market was the second largest of the global market in 2012. Rising geriatric population in European Union is one of the major market drivers in this region as the geriatric group is more prone to suffer from arthritis. Moreover, extensive support and funding provided by European government for regenerative medicine would further accentuate the market growth in this region.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419

Asia-Pacific was observed to be a promising market for regenerative medicine bone and joint application during the study period owing to the demand of bone graft substitute in this region. This region is considered as an emerging market and is estimated to grow at the highest CAGR from 2013 to 2019. Manufacturer of regenerative medicine bone and joint products are expanding their operation in Asian countries (India, China, Japan and South Korea) as these economies hold immense potential for regenerative medicine bone and joint application. For instance, in May 2013, Smith & Nephew acquired Sushrut Surgical Pvt. Ltd. an Indian medical technology company. Sushrut Surgicals product portfolio includes trauma implants and instruments, spine and limb salvage products. This acquisition would expand and enhance the product offerings of Smith & Nephew and would also assist in capturing lucrative market share in Asia-Pacific region. In terms of key players the global regenerative medicine bone and joint application market is highly fragmented that comprises of DePuy Synthes, Inc. (HEALOS Bone Graft), Medtronic, Inc. (INFUSE Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute) and Zimmer Holdings, Inc (CopiOs Bone Void Filler).